Literature DB >> 21470878

RADIAL: a novel primary graft failure risk score in heart transplantation.

Javier Segovia1, M Dolores G Cosío, Juan M Barceló, Manuel Gómez Bueno, Pablo García Pavía, Raúl Burgos, Santiago Serrano-Fiz, Carlos García-Montero, Evaristo Castedo, Juan Ugarte, Luis Alonso-Pulpón.   

Abstract

BACKGROUND: Primary graft failure (PGF) is the leading cause of early mortality after heart transplantation (HT). Our aim is to propose a working definition of PGF and to develop a predictive risk score.
METHODS: PGF was defined by four criteria reflecting significant myocardial dysfunction, severe hemodynamic impairment, early onset after HT, and absence of secondary causes of graft dysfunction. We identified independent risk factors for PGF in a derivation series of 621 HTs and constructed a predictive model. After proving its internal consistency we tested the model in a prospective validation series.
RESULTS: The incidence and lethality of PGF in our series were 9% and 80%, respectively. We identified 6 multivariate risk factors for PGF (Right atrial pressure ≥ 10 mm Hg, recipient Age ≥ 60 years, Diabetes mellitus, Inotrope dependence, donor Age ≥ 30 years, Length of ischemic time ≥ 240 minutes--i.e., RADIAL). Analysis of isolated right ventricular failure showed similar predictors. The RADIAL score was obtained by adding 1 point for each of these factors present in a given HT. PGF incidence increased significantly as the RADIAL score increased (p < 0.001 for trend). Rates of actual and predicted PGF incidence for RADIAL subgroups showed a good correlation (C-statistic = 0.74). In a prospective validation cohort, RADIAL score kept its predictive ability.
CONCLUSIONS: PGF as defined by these criteria showed a high impact on early post-HT mortality in our series. The RADIAL score showed good ability to predict the development of PGF, and could be useful in the prevention and early treatment of this complication.
Copyright © 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21470878     DOI: 10.1016/j.healun.2011.01.721

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  27 in total

1.  Salvage of severe primary graft dysfunction following heart transplantation using extracorporeal life support.

Authors:  Katalin Martits-Chalangari; Omar Hernandez; Aayla K Jamil; Huanying Qin; Joost Felius; Samuel Jacob; Brian Lima; Aldo Rafael; Gonzalo V Gonzalez-Stawinski; Melody J Sherwood; Shelley A Hall
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-10-18

2.  Continuous-flow mechanical circulatory support is not associated with early graft failure: An analysis of the International Society for Heart and Lung Transplantation registry.

Authors:  Kevin J Clerkin; Donna M Mancini; Josef Stehlik; Wida S Cherikh; Lars H Lund
Journal:  Clin Transplant       Date:  2019-11-26       Impact factor: 2.863

Review 3.  Outcomes following cardiac transplantation in adults.

Authors:  Sai Bhagra; Jayan Parameshwar
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-02-15

4.  Incidence, etiology, and outcome of primary graft dysfunction in adult heart transplant recipients: a single-center experience in Japan.

Authors:  Osamu Seguchi; Tomoyuki Fujita; Yoshihiro Murata; Haruki Sunami; Takuma Sato; Takuya Watanabe; Seiko Nakajima; Kensuke Kuroda; Eriko Hisamatsu; Takamasa Sato; Masanobu Yanase; Hiroki Hata; Kyoichi Wada; Hatsue Ishibashi-Ueda; Junjiro Kobayashi; Takeshi Nakatani
Journal:  Heart Vessels       Date:  2015-02-15       Impact factor: 2.037

5.  Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality.

Authors:  Lauren B Cooper; Robert J Mentz; Leah B Edwards; Amber R Wilk; Joseph G Rogers; Chetan B Patel; Carmelo A Milano; Adrian F Hernandez; Josef Stehlik; Lars H Lund
Journal:  J Heart Lung Transplant       Date:  2016-07-17       Impact factor: 10.247

6.  Cardiac transplantation can be safely performed using selected diabetic donors.

Authors:  Sharven Taghavi; Senthil N Jayarajan; Lynn M Wilson; Eugene Komaroff; Jeffrey M Testani; Abeel A Mangi
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03-13       Impact factor: 5.209

7.  Ten-year experience with extended criteria cardiac transplantation.

Authors:  Marc D Samsky; Chetan B Patel; Ashleigh Owen; Phillip J Schulte; Jacob Jentzer; Paul B Rosenberg; G Michael Felker; Carmelo A Milano; Adrian F Hernandez; Joseph G Rogers
Journal:  Circ Heart Fail       Date:  2013-10-02       Impact factor: 8.790

8.  Renal Outcomes in Patients Bridged to Heart Transplant With a Left Ventricular Assist Device.

Authors:  Oliver K Jawitz; Marat Fudim; Vignesh Raman; Vanessa Blumer; Kadir Caliskan; Adam D DeVore; Robert J Mentz; Carmelo Milano; Osama Soliman; Joseph Rogers; Chetan B Patel
Journal:  Ann Thorac Surg       Date:  2020-01-03       Impact factor: 4.330

9.  Reassessing Recipient Mortality Under the New Heart Allocation System: An Updated UNOS Registry Analysis.

Authors:  Oliver K Jawitz; Marat Fudim; Vignesh Raman; Benjamin S Bryner; Adam D DeVore; Robert J Mentz; Carmelo Milano; Chetan B Patel; Jacob N Schroder; Joseph G Rogers
Journal:  JACC Heart Fail       Date:  2020-05-14       Impact factor: 12.035

10.  Amiodarone Use Prior to Cardiac Transplant Impacts Early Post-Transplant Survival.

Authors:  Salman S Allana; Furqan A Rajput; Jason W Smith; Lucian Lozonschi; Jinn-Ing Liou; Maryl Johnson; Takushi Kohmoto; Ravi Dhingra
Journal:  Cardiovasc Drugs Ther       Date:  2020-10-19       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.